Commonwealth Equity Services’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $980K | Sell |
5,027
-617
| -11% | -$128K | ﹤0.01% | 2731 |
|
|
2026
Q1 | $1.27M | Sell |
5,644
-4,746
| -46% | -$1.18M | ﹤0.01% | 2408 |
|
|
2025
Q4 | $2.5M | Sell |
10,390
-1,331
| -11% | -$340K | ﹤0.01% | 1810 |
|
|
2025
Q3 | $3.21M | Sell |
11,721
-3,914
| -25% | -$1.07M | ﹤0.01% | 1659 |
|
|
2025
Q2 | $4.03M | Buy |
15,635
+835
| +6% | +$199K | 0.01% | 1472 |
|
|
2025
Q1 | $3.31M | Buy |
14,800
+1,561
| +12% | +$364K | ﹤0.01% | 1564 |
|
|
2024
Q4 | $3.03M | Buy |
13,239
+3,417
| +35% | +$823K | ﹤0.01% | 1573 |
|
|
2024
Q3 | $2.4M | Buy |
9,822
+1,179
| +14% | +$263K | ﹤0.01% | 1697 |
|
|
2024
Q2 | $1.66M | Sell |
8,643
-801
| -8% | -$163K | ﹤0.01% | 1920 |
|
|
2024
Q1 | $1.87M | Buy |
9,444
+4
| +0% | +$733 | ﹤0.01% | 1832 |
|
|
2023
Q4 | $1.62M | Buy |
9,440
+911
| +11% | +$140K | ﹤0.01% | 1835 |
|
|
2023
Q3 | $1.26M | Sell |
8,529
-699
| -8% | -$126K | ﹤0.01% | 1911 |
|
|
2023
Q2 | $2.02M | Buy |
9,228
+861
| +10% | +$192K | ﹤0.01% | 1612 |
|
|
2023
Q1 | $1.83K | Buy |
8,367
+315
| +4% | +$68.3K | ﹤0.01% | 1617 |
|
|
2022
Q4 | $1.68M | Buy |
8,052
+137
| +2% | +$30.1K | ﹤0.01% | 1619 |
|
|
2022
Q3 | $1.73M | Buy |
7,915
+202
| +3% | +$46K | ﹤0.01% | 1515 |
|
|
2022
Q2 | $1.62M | Buy |
7,713
+67
| +0.9% | +$14.3K | ﹤0.01% | 1560 |
|
|
2022
Q1 | $1.85M | Sell |
7,646
-45
| -0.6% | -$10.9K | ﹤0.01% | 1554 |
|
|
2021
Q4 | $2M | Buy |
7,691
+96
| +1% | +$24.9K | ﹤0.01% | 1487 |
|
|
2021
Q3 | $2M | Sell |
7,595
-43
| -0.6% | -$11.8K | 0.01% | 1421 |
|
|
2021
Q2 | $1.88M | Buy |
7,638
+549
| +8% | +$115K | ﹤0.01% | 1462 |
|
|
2021
Q1 | $1.38M | Buy |
7,089
+51
| +0.7% | +$10.2K | ﹤0.01% | 1576 |
|
|
2020
Q4 | $1.5M | Buy |
7,038
+488
| +7% | +$97.3K | ﹤0.01% | 1395 |
|
|
2020
Q3 | $1.12M | Sell |
6,550
-67
| -1% | -$12.4K | ﹤0.01% | 1435 |
|
|
2020
Q2 | $1.27M | Buy |
6,617
+991
| +18% | +$162K | ﹤0.01% | 1278 |
|
|
2020
Q1 | $828K | Buy |
5,626
+1,228
| +28% | +$196K | ﹤0.01% | 1363 |
|
|
2019
Q4 | $681K | Sell |
4,398
-354
| -7% | -$51K | ﹤0.01% | 1674 |
|
|
2019
Q3 | $642K | Sell |
4,752
-115
| -2% | -$15.1K | ﹤0.01% | 1653 |
|
|
2019
Q2 | $593K | Buy |
4,867
+132
| +3% | +$14.6K | ﹤0.01% | 1675 |
|
|
2019
Q1 | $492K | Sell |
4,735
-191
| -4% | -$19.7K | ﹤0.01% | 1767 |
|
|
2018
Q4 | $560K | Sell |
4,926
-473
| -9% | -$50.7K | ﹤0.01% | 1568 |
|
|
2018
Q3 | $622K | Buy |
5,399
+521
| +11% | +$57.1K | ﹤0.01% | 1640 |
|
|
2018
Q2 | $505K | Sell |
4,878
-1,892
| -28% | -$191K | ﹤0.01% | 1746 |
|
|
2018
Q1 | $666K | Buy |
6,770
+151
| +2% | +$14.3K | ﹤0.01% | 1503 |
|
|
2017
Q4 | $561K | Buy |
6,619
+9
| +0.1% | +$744 | ﹤0.01% | 1606 |
|
|
2017
Q3 | $509K | Sell |
6,610
-119
| -2% | -$9.1K | ﹤0.01% | 1610 |
|
|
2017
Q2 | $524K | Buy |
6,729
+574
| +9% | +$41.1K | ﹤0.01% | 1548 |
|
|
2017
Q1 | $443K | Buy |
6,155
+575
| +10% | +$39.7K | ﹤0.01% | 1577 |
|
|
2016
Q4 | $346K | Buy |
5,580
+175
| +3% | +$10.7K | ﹤0.01% | 1672 |
|
|
2016
Q3 | $350K | Buy |
5,405
+28
| +0.5% | +$1.86K | ﹤0.01% | 1604 |
|
|
2016
Q2 | $340K | Buy |
5,377
+18
| +0.3% | +$1.06K | ﹤0.01% | 1585 |
|
|
2016
Q1 | $310K | Sell |
5,359
-54
| -1% | -$3.06K | ﹤0.01% | 1617 |
|
|
2015
Q4 | $291K | Buy |
+5,413
| New | +$305K | ﹤0.01% | 1622 |
|
|
2014
Q4 | – | Sell |
-18,784
| Closed | -$926K | – | 2147 |
|
|
2014
Q3 | $926K | Sell |
18,784
-935
| -5% | -$47.6K | 0.01% | 910 |
|
|
2014
Q2 | $998K | Buy |
19,719
+150
| +0.8% | +$7.43K | 0.01% | 867 |
|
|
2014
Q1 | $875K | Buy |
+19,569
| New | +$879K | 0.01% | 874 |
|
|
2013
Q4 | – | Sell |
-12,600
| Closed | -$666K | – | 1971 |
|
|
2013
Q3 | $666K | Sell |
12,600
-8,811
| -41% | -$427K | 0.01% | 934 |
|
|
2013
Q2 | $966K | Buy |
+21,411
| New | +$1.02M | 0.02% | 689 |
|
Other funds holding RMD
TIA
WF
VF
AT
AS
TIM
Commonwealth Equity Services's RMD Position: Q2 2026 in Review
Commonwealth Equity Services reduced its ResMed (RMD) stake by 11% in Q2 2026, selling an estimated $128K and leaving 5,027 shares worth $980K. The position accounts for ﹤0.01% of the portfolio, ranked #2731.
Commonwealth Equity Services first reported a position in RMD in Q2 2013 and has held it in 48 quarters since. The position peaked at $4.03M in Q2 2025. 319 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Commonwealth Equity Services held 5,027 shares of ResMed worth $980K as of Q2 2026.
- Commonwealth Equity Services sold 617 ResMed shares in Q2 2026, an estimated $128K.
- ResMed made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #2731 holding.
- Commonwealth Equity Services first reported a position in ResMed in Q2 2013 and has held it in 48 quarters since.
- Commonwealth Equity Services's ResMed position peaked at $4.03M in Q2 2025.
- 319 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.